Subscribe to our Newsletters !!

    Kumar Jeetendra

    Access to Whole-Genome Sequencing for Genetic Disease Testing :Illumina and Harvard Pilgrim Health Care

    SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)– Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey

    Apex Chromatography Pvt. Ltd. adds colour and positivity to it’s refreshed brand identity with new logo.

    Hyderabad: 21st December 2020: Apex Chromatography Pvt Ltd, the leading provider of chromatography consumables, powder Characterization, Inhalation testing equipments in India, announced today the launch of its new corporate brand identity, redesigned logo. These changes come at a time when the company is evolving its service offerings and expanding its reach. “2020 has been a

    Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel

    Waltham, Mass – December 21, 2020 – Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution. Building on Cytel’s advanced software platform and leading biometrics services

    WHO Europe to convene participants over new virus version

    The World Health Organization in Europe said Tuesday it could induce its members to discuss how to manage a new variant of this novel coronavirus found in the UK. Hans Kluge, WHO’s regional director for Europe said on Twitter the organisation had been closely monitoring the spread of this new variant and would”convene member states

    New coronavirus version now no longer out of control, says WHO

    The new coronavirus version discovered in Britain with a higher transmission rate is not yet out of control and can be contained using existing measures, the World Health Organization said on Monday. “We have had a much higher (contamination rate) at various points in this event and we have got it under control,” WHO’s emergencies

    Trinity crew uncovers mutations connected with early onset dementia

    Researchers at Trinity College Dublin today announced a significant advance in our knowledge of an early onset form of dementia which may also advance our understanding of conditions such as Alzheimer’s disease. Adult onset Leukoencephalopathy with axonal Spheroids and Pigmented glia (ALSP) is an ultra-rare condition characterized by mutations in a gene named Colony stimulating

    British MedTech Rinicare poised to respond to the challenges of the new healthcare environment

    Manchester based clinician-led digital health company, Rinicare, has further strengthened its foundations with the appointment of a new Managing Director and the closure of a finance round, which included investment from the Future Fund. Whilst many have long since appreciated the benefits digital technology can bring to healthcare, the scale and pace of digital transformation

    Docking Station Enables a Consistent Sample Tube (De)Capping Action

    Using the Docking Station in combination with the Screw Cap Recappers, a consistent capping and decapping action is assured, allowing research laboratories to recap 96-well, 48-well and 24-well format sample storage tubes securely and uniformly for an optimal sealing performance. Designed in conjunction with several leading laboratories, the cost-effective handheld devices offer users the ability

    AstraZeneca says its vaccine need to be powerful in opposition to new coronavirus variant

    British drugmaker AstraZeneca Plc told Reuters on Tuesday that its COVID-19 vaccine should be effective against the new coronavirus version, including that studies were under way to completely probe the effect of the mutation. “AZD1222 (AstraZeneca’s vaccine candidate) contains the genetic material of this SARS-CoV-2 virus spike protein, as well as the changes to the